🇺🇸 FDA
Pipeline program

Behavior Therapy

NIDA-CTN-0020-1

Phase 3 other completed

Quick answer

Behavior Therapy for Substance-Related Disorders is a Phase 3 program (other) at BRIGHT MINDS BIOSCIENCES INC. with 3 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Substance-Related Disorders
Phase
Phase 3
Modality
other
Status
completed

Clinical trials